The PubMed entry for this review identifies a focused literature synthesis on intratumoral microbiota and their role in tumorigenesis, framed as a “double-edged sword.” The article is listed as a review in Chin Med J (Engl), volume 139, issue 18, pages 2706–2720 (2026). The PubMed record provides bibliographic metadata, author names, institutional affiliations, and unique identifiers (PMID 42409802; DOI 10.1097/CM9.0000000000004178).
Authors listed include Xinyue Fu and colleagues from multiple institutions (notably West China Hospital, Sichuan University, and Tongji University Cancer Centre). The PubMed record classifies the piece as a review article. Beyond author names and affiliations, the PubMed excerpt does not present the review’s abstract or the body text; therefore, the specific literature covered, methodology for article selection or synthesis, and the chronology of included studies are not available from this source page.
The review’s title explicitly frames intratumoral microbiota as having dual, potentially opposing effects on cancer development and progression. That framing signals the authors discuss both tumor-promoting and tumor-suppressing influences of microbes residing within tumors. However, the PubMed excerpt provided here does not include the review’s arguments, evidence summaries, or specific examples of microbial taxa, pathways, or tumor types addressed.
The PubMed page includes the following verifiable details from the record:
A full-text link is indicated on the PubMed page (journal/LinkOut). To read the review’s substantive content, methods, evidence synthesis, and conclusions, consult the journal platform via the DOI or institutionally available full-text services.
The PubMed excerpt on which this summary is based does not include the abstract or the review text. As a result, the following items are not reported in the provided source and cannot be inferred:
Any attempt to restate or paraphrase those items would risk introducing facts not present in the source excerpt.
From the bibliographic record and title alone, clinicians and researchers can take away that intratumoral microorganisms are an active area of scholarly review and that the literature acknowledges both beneficial and harmful effects on cancer biology. To apply the authors’ synthesis in clinical practice or research planning, obtaining and appraising the full text is necessary. The PubMed entry signals the review may be relevant for oncology clinicians interested in tumor microenvironment biology, microbiome research, biomarker development, and microbiota-targeted interventions, but concrete clinical or translational guidance is not extractable from the excerpted page.
To retrieve the review’s substantive content and to evaluate its evidence and recommendations, use one of the following approaches:
The PubMed record documents a 2026 review titled “Intratumoral microbiota in tumorigenesis: A double-edged sword” (PMID 42409802) that addresses the dual roles of microbes within tumors. The provided source excerpt gives bibliographic and authorship information but does not include the review’s abstract or main content. Detailed findings, mechanisms, and recommendations reported by the authors are therefore not available from this excerpt and require consultation of the full article.